Literature DB >> 6703655

Neurological disorders associated with deficiency of glutamate dehydrogenase.

A Plaitakis, S Berl, M D Yahr.   

Abstract

Glutamate dehydrogenase (GDH) activity was measured in leukocytes from 88 patients with various types of degenerative neurological disorders affecting primarily the cerebellum and/or the basal ganglia, and 26 healthy control subjects. Twelve patients with slowly progressive multiple-system atrophic disorders were found to have a partial deficiency of this enzyme (52% of control level). The majority of these patients evidenced a constellation of neurological findings consistent with the diagnosis of olivopontocerebellar atrophy, although others were atypical in their neurological manifestations. Thus, GDH-deficient patients were encountered with predominantly extrapyramidal manifestations (atypical Parkinson's disease), cerebellar dysfunction with peripheral neuropathy, or anterior horn cell signs, suggesting that a pleomorphic phenotypic expression of the enzymatic deficiency may occur. Seven cases of GDH deficiency were familial and 5 were sporadic. The former patient group consisted of siblings of either sex, but no parents or offspring were affected. The genetic pattern of the disorder is compatible with autosomal recessive inheritance. Patients with dominantly inherited olivopontocerebellar atrophy or other types of cerebellar or basal ganglia degenerative neurological disorders showed normal GDH activity. Leukocyte GDH was fractionated into "particulate-heat labile" and "soluble-heat stable" components. In the patients the decrease in activity was limited to the "particulate-heat labile" component. A genetic mutation of a GDH "isoenzyme" may occur in some patients with multiple-system degeneration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6703655     DOI: 10.1002/ana.410150206

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  32 in total

1.  Isolation and characterization of cDNA clones encoding human liver glutamate dehydrogenase: evidence for a small gene family.

Authors:  G Mavrothalassitis; G Tzimagiorgis; A Mitsialis; V Zannis; A Plaitakis; J Papamatheakis; N Moschonas
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Degenerative neurological disorders associated with deficiency of glutamate dehydrogenase.

Authors:  V S Kostić; L Mojsilović; M Stojanović
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

Review 3.  The discovery of human of GLUD2 glutamate dehydrogenase and its implications for cell function in health and disease.

Authors:  Pullanipally Shashidharan; Andreas Plaitakis
Journal:  Neurochem Res       Date:  2013-12-19       Impact factor: 3.996

4.  Leukocyte glutamate dehydrogenase in patients with degenerative neurological disorders.

Authors:  A Plaitakis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

5.  The subcellular localization of glutamate dehydrogenase (GDH): is GDH a marker for mitochondria in brain?

Authors:  J C Lai; K F Sheu; Y T Kim; D D Clarke; J P Blass
Journal:  Neurochem Res       Date:  1986-05       Impact factor: 3.996

Review 6.  Glutamate: its role in learning, memory, and the aging brain.

Authors:  W J McEntee; T H Crook
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 7.  Heterogeneous cellular distribution of glutamate dehydrogenase in brain and in non-neural tissues.

Authors:  Cleanthe Spanaki; Dimitra Kotzamani; Zoe Petraki; Elias Drakos; Andreas Plaitakis
Journal:  Neurochem Res       Date:  2014-01-17       Impact factor: 3.996

Review 8.  Cerebral ischemia revisited: new insights as revealed using in vitro brain slice preparations.

Authors:  A Schurr; B M Rigor
Journal:  Experientia       Date:  1989-08-15

9.  Glutamate dehydrogenase isoforms with N-terminal (His)6- or FLAG-tag retain their kinetic properties and cellular localization.

Authors:  Kamilla Pajęcka; Camilla Wendel Nielsen; Anne Hauge; Ioannis Zaganas; Lasse K Bak; Arne Schousboe; Andreas Plaitakis; Helle S Waagepetersen
Journal:  Neurochem Res       Date:  2013-04-26       Impact factor: 3.996

10.  Mitochondrial enzymes in hereditary ataxias.

Authors:  K F Sheu; J P Blass; J M Cedarbaum; Y T Kim; B J Harding; J DeCicco
Journal:  Metab Brain Dis       Date:  1988-06       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.